Market Overview:
The global fast-absorption bioabsorbable stents market is expected to grow at a CAGR of 10.8% from 2018 to 2030. The market growth is attributed to the increasing prevalence of coronary artery diseases (CAD) and peripheral artery diseases (PAD), technological advancements in stent design, and rising demand for minimally invasive procedures. However, the high cost of these devices may restrain the growth of this market during the forecast period. Based on type, the global fast-absorption bioabsorbable stents market is segmented into polymer-based stents and metallic stents. The polymer-based segment is expected to grow at a higher CAGR than the metallic segment during the forecast period owing to its advantages such as biocompatibility, nonthrombogenicity, and degradation kinetics that match with natural tissue remodeling processes. Based on application, the global fast-absorption bioabsorbable stents market is divided into CAD and PAD segments.
Product Definition:
A bioabsorbable stent is a type of medical device made from materials that the body can absorb. As the name suggests, a bioabsorbable stent is designed to be slowly absorbed by the body over time, leaving behind only healthy tissue. This contrasts with traditional metal stents, which are often left in place permanently.
Polymer-based Stents:
Polymer-based stents are made of synthetic polymers and are used for the treatment of coronary artery disease. The growth factor in this market is increasing demand for minimally invasive surgeries, development of drug-eluting stents, and growing prevalence of target diseases such as Coronary Artery Disease (CAD) & peripheral vascular disease.
Metallic Stents:
Metallic stents are used in bioabsorbable stents to prevent or slow the progression of a disease. Metallic stents are made up of materials such as stainless steel, titanium, and nickel. These metals provide strength and durability to the device they are used in.
Application Insights:
The coronary artery diseases segment dominated the global market in terms of revenue share in 2017. This can be attributed to the increasing prevalence of target diseases, such as heart attacks and stroke. In addition, growing awareness about early treatment is also expected to contribute significantly towards segment growth during the forecast period.
On the other hand, peripheral artery diseases are expected to witness lucrative growth over the forecast period due to rising geriatric population across countries such as China and India coupled with increasing cases of obesity and smoking rates globally. Moreover, an increase in percutaneous coronary intervention procedures also boosts segment growth during future years owing to its benefits over open surgery for treating patients with stable angina or minimal symptoms who cannot undergo bypass surgery or have declined this option due these risks associated with it (too big a risk). Henceforth, these factors are anticipated drive demand for peripheral arteries stents globally which is further anticipated to boost market penetration over next few years.
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of a large number of local players and high adoption rate for advanced medical devices. The region is expected to maintain its dominance over the forecast period due to increasing incidence rates of coronary artery diseases (CAD) and peripheral artery diseases (PAD). In addition, rising government initiatives for promoting quality healthcare services are anticipated to fuel regional growth.
Asia Pacific is expected to be one of the fastest-growing regions during the forecast period owing with growing geriatric population, improving economic conditions, increase in disposable income levels coupled with rise in consumer awareness regarding early diagnosis & treatment options for various cardiovascular disorders such as CAD & PAD.
Growth Factors:
- Technological advancements in the field of bioabsorbable stents
- Increasing incidences of cardiovascular diseases
- Rising demand for minimally invasive procedures
- Growing awareness about the benefits of bioabsorbable stents
- Rising healthcare expenditure
Scope Of The Report
Report Attributes
Report Details
Report Title
Fast- absorption Bioabsorbable Stents Market Research Report
By Type
Polymer-based Stents, Metallic Stents
By Application
Coronary Artery Diseases, Peripheral Artery Diseases
By Companies
Abbott Laboratories (U.S.), BIOTRONIK SE & Co. KG (Germany), REVA Medical, Inc. (U.S.), Elixir Medical Corporation (U.S.), Kyoto Medical Planning Co., Ltd. (Japan), Abbott Laboratories (U.S.)
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
139
Number of Tables & Figures
98
Customization Available
Yes, the report can be customized as per your need.
Global Fast- absorption Bioabsorbable Stents Market Report Segments:
The global Fast- absorption Bioabsorbable Stents market is segmented on the basis of:
Types
Polymer-based Stents, Metallic Stents
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Coronary Artery Diseases, Peripheral Artery Diseases
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott Laboratories (U.S.)
- BIOTRONIK SE & Co. KG (Germany)
- REVA Medical, Inc. (U.S.)
- Elixir Medical Corporation (U.S.)
- Kyoto Medical Planning Co., Ltd. (Japan)
- Abbott Laboratories (U.S.)
Highlights of The Fast- absorption Bioabsorbable Stents Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Polymer-based Stents
- Metallic Stents
- By Application:
- Coronary Artery Diseases
- Peripheral Artery Diseases
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Fast- absorption Bioabsorbable Stents Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Fast-absorption bioabsorbable stents are a type of medical device that is inserted into the body to help support an artery. These stents are made from a material that absorbs quickly and breaks down in the body, which helps reduce the risk of complications.
Some of the key players operating in the fast- absorption bioabsorbable stents market are Abbott Laboratories (U.S.), BIOTRONIK SE & Co. KG (Germany), REVA Medical, Inc. (U.S.), Elixir Medical Corporation (U.S.), Kyoto Medical Planning Co., Ltd. (Japan), Abbott Laboratories (U.S.).
The fast- absorption bioabsorbable stents market is expected to register a CAGR of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Fast- absorption Bioabsorbable Stents Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Fast- absorption Bioabsorbable Stents Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Fast- absorption Bioabsorbable Stents Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Fast- absorption Bioabsorbable Stents Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Fast- absorption Bioabsorbable Stents Market Size & Forecast, 2020-2028 4.5.1 Fast- absorption Bioabsorbable Stents Market Size and Y-o-Y Growth 4.5.2 Fast- absorption Bioabsorbable Stents Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Polymer-based Stents
5.2.2 Metallic Stents
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Coronary Artery Diseases
6.2.2 Peripheral Artery Diseases
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Fast- absorption Bioabsorbable Stents Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Fast- absorption Bioabsorbable Stents Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Polymer-based Stents
9.6.2 Metallic Stents
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Coronary Artery Diseases
9.10.2 Peripheral Artery Diseases
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Polymer-based Stents
10.6.2 Metallic Stents
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Coronary Artery Diseases
10.10.2 Peripheral Artery Diseases
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Polymer-based Stents
11.6.2 Metallic Stents
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Coronary Artery Diseases
11.10.2 Peripheral Artery Diseases
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Polymer-based Stents
12.6.2 Metallic Stents
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Coronary Artery Diseases
12.10.2 Peripheral Artery Diseases
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Polymer-based Stents
13.6.2 Metallic Stents
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Coronary Artery Diseases
13.10.2 Peripheral Artery Diseases
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Fast- absorption Bioabsorbable Stents Market: Competitive Dashboard
14.2 Global Fast- absorption Bioabsorbable Stents Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott Laboratories (U.S.)
14.3.2 BIOTRONIK SE & Co. KG (Germany)
14.3.3 REVA Medical, Inc. (U.S.)
14.3.4 Elixir Medical Corporation (U.S.)
14.3.5 Kyoto Medical Planning Co., Ltd. (Japan)
14.3.6 Abbott Laboratories (U.S.)